title: Changes in plasma zinc, copper, iron, and hepatic metallothionein in adjuvant-induced arthritis treated with cyclosporin.
abstract: The early changes in hepatic metallothionein (MT) and plasma zinc (Zn), copper (Cu), and iron (Fe) were investigated during the induction of adjuvant (AJ) arthritis in rats in conjunction with cyclosporin (CsA) treatment. Plasma Zn decreased after AJ injection (60% of control values at 8 h), and this was associated with a 4.5-fold increase in hepatic MT at 8 h. Plasma Zn was lowest at 16 h (40% of control), whereas hepatic MT concentrations increased to a maximum of 20-fold at 16 h. Changes in plasma Fe paralleled those of Zn, whereas plasma Cu levels were increased. Plasma metal and hepatic MT concentrations returned toward normal from d 1-7. At d 14, when marked paw swelling was apparent, hepatic MT and plasma Cu were again increased and plasma Zn decreased. Administration of CsA decreased MT induction in rats injected with AJ and also caused a marked recovery in plasma Zn and Fe levels. These changes were small but significant even in the early stages (up to 24 h) after AJ injection and were followed by a sustained improvement in all parameters, corresponding to the nonappearance of clinical arthropathy in CsA-treated rats. TNF-alpha and IL-6 production by peritoneal macrophages isolated from AJ-injected rats was significantly decreased by CsA treatment at d 7 and 14. The inhibition of hepatic MT induction during acute and chronic inflammation by cyclosporin emphasizes the role of the immune system in altered metal homeostasis in inflammation.
authors.affiliation: Division of Clinical Chemistry, Institute of Medical and Veterinary Science, Adelaide, Australia.
authors.forename: A M
authors.initials: AM
authors.lastname: Rofe
authors.forename: J C
authors.initials: JC
authors.lastname: Philcox
authors.forename: D R
authors.initials: DR
authors.lastname: Haynes
authors.forename: M W
authors.initials: MW
authors.lastname: Whitehouse
authors.forename: P
authors.initials: P
authors.lastname: Coyle
mesh_terms: D000818:Animals; D001169:Arthritis, Experimental / Q000188:drug therapy / Q000378:metabolism*; D001835:Body Weight / Q000187:drug effects; D003300:Copper / Q000097:blood; D016572:Cyclosporine / Q000494:pharmacology / Q000627:therapeutic use*; D004435:Eating / Q000187:drug effects; D015850:Interleukin-6 / Q000032:analysis; D007501:Iron / Q000097:blood*; D008099:Liver / Q000737:chemistry*; D008264:Macrophages / Q000737:chemistry; D008297:Male; D008668:Metallothionein / Q000378:metabolism*; D010529:Peritoneal Cavity / Q000166:cytology; D051381:Rats; D014131:Trace Elements / Q000097:blood*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D015032:Zinc / Q000097:blood
chemical_list: D015850:Interleukin-6; D014131:Trace Elements; D014409:Tumor Necrosis Factor-alpha; D003300:Copper; D016572:Cyclosporine; D008668:Metallothionein; D007501:Iron; D015032:Zinc